Proton magnetic resonance spectroscopic imaging in the border zone of gliomas: Correlation of metabolic and histological changes at low tumor infiltration - Initial results

Investigative Radiology

Volumn 42, Issue 4, 2007, Pages 218-223

  Stadlbauer, Andreas ^a,c   Nimsky, Christopher ^a   Buslei, Rolf ^a   Pinker, Katja ^b   Gruber, Stephan ^b   Hammen, Thilo ^a   Buchfelder, Michael ^a   Ganslandt, Oliver ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c NONE   (Germany)

Author keywords

Glioma; Histopathology; MR spectroscopy; Quantification; Tumor border

Indexed keywords

CHOLINE DERIVATIVE; CREATINE; N ACETYLASPARTIC ACID; PROTON;

ADULT; ARTICLE; CELL INFILTRATION; CELL MEMBRANE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GLIOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; STEREOTAXIC SURGERY; STUDENT T TEST; TUMOR CELL;

EID: 33947107021     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rli.0000255812.61435.67     Document Type: Article

References (32)

1. Negendank WG, Sauter R, Brown TR, et al. Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study. J Neurosurg. 1996;84:449-458.
2. Majos C, Alonso J, Aguilera C, et al. Adult primitive neuroectodermal tumor: proton MR spectroscopic findings with possible application for differential diagnosis. Radiology. 2002;225:556-566.
3. Michaelis T, Merboldt KD, Bruhn H, et al. Absolute concentrations of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra. Radiology. 1993;187:219-227.
4. Sabatier J, Gilard V, Malet-Martino M, et al. Characterization of choline compounds with in vitro 1H magnetic resonance spectroscopy for the discrimination of primary brain tumors. Invest Radiol. 1999;34:230-235.
5. Urenjak J, Williams SR, Gadian DG, et al. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci. 1993;13:981-989.
6. Kemp GJ. Non-invasive methods for studying brain energy metabolism: what they show and what it means. Dev Neurosci. 2000;22:418-428.
7. Dowling C, Bollen AW, Noworolski SM, et al. Preoperative proton MR spectroscopic imaging of brain tumors: correlation with histopathologic analysis of resection specimens. AJNR Am J Neuroradiol. 2001;22:604-612.
8. Croteau D, Scarpace L, Hearshen D, et al. Correlation between magnetic resonance spectroscopy imaging and image-guided biopsies: semiquantitative and qualitative histopathological analyses of patients with untreated glioma. Neurosurgery. 2001;49:823-829.
9. Stadlbauer A, Gruber S, Nimsky C, et al. Preoperative grading of gliomas by using metabolite quantification with high-spatial-resolution proton MR spectroscopic imaging. Radiology. 2006;238:958-969.
10. Chiang IC, Kuo YT, Lu CY, et al. Distinction between high-grade gliomas and solitary metastases using peritumoral 3-T magnetic resonance spectroscopy, diffusion, and perfusion imagings. Neuroradiology. 2004;46:619-627.
11. Kamada K, Houkin K, Iwasaki Y, et al. In vivo proton magnetic resonance spectroscopy for metabolic changes of human brain edema. Neurol Med Chir (Tokyo). 1994;34:676-681.
12. Walecki J, Tarasow E, Kubas B, et al. Hydrogen-1 MR spectroscopy of the peritumoral zone in patients with cerebral glioma: assessment of the value of the method. Acad Radiol. 2003;10:145-153.
13. Law M, Cha S, Knopp EA, et al. High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging. Radiology. 2002;222:715-721.
14. Law M, Yang S, Wang H, et al. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol. 2003;24:1989-1998.
15. Gruber S, Frey R, Mlynarik V, et al. Quantification of metabolic differences in the frontal brain of depressive patients and controls obtained by 1H-MRS at 3 Tesla. Invest Radiol. 2003;38:403-408.
16. Vuori K, Kankaanranta L, Hakkinen AM, et al. Low-grade gliomas and focal cortical developmental malformations: differentiation with proton MR spectroscopy. Radiology. 2004;230:703-708.
17. Li BS, Wang H, Gonen O. Metabolite ratios to assumed stable creatine level may confound the quantification of proton brain MR spectroscopy. Magn Reson Imaging. 2003;21:923-928.
18. Stadlbauer A, Moser E, Gruber S, et al. Integration of biochemical images of a tumor into frameless stereotaxy achieved using a magnetic resonance imaging/magnetic resonance spectroscopy hybrid data set. J Neurosurg. 2004;101:287-294.
19. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med. 1993;30:672-679.
20. McLean MA, Woermann FG, Barker GJ, et al. Quantitative analysis of short echo time (1)H-MRSI of cerebral gray and white matter. Magn Reson Med. 2000;44:401-411.
21. Isobe T, Matsumura A, Anno I, et al. Quantification of cerebral metabolites in glioma patients with proton MR spectroscopy using T2 relaxation time correction. Magn Reson Imaging. 2002;20:343-349.
22. Blumcke I, Becker AJ, Normann S, et al. Distinct expression pattern of microtubule-associated protein-2 in human oligodendrogliomas and glial precursor cells. J Neuropathol Exp Neurol. 2001;60:984-993.
23. Blumcke I, Muller S, Buslei R, et al. Microtubule-associated protein-2 immunoreactivity: a useful tool in the differential diagnosis of low-grade neuroepithelial tumors. Acta Neuropathol (Berl). 2004;108:89-96.
24. Ganslandt O, Stadlbauer A, Fahlbusch R, et al. Proton magnetic resonance spectroscopic imaging integrated into image-guided surgery: correlation to standard magnetic resonance imaging and tumor cell density. Neurosurgery. 2005;56:291-298.
25. Sokahl RR, Rohlf FJ. Biometry. 3rd ed. New York, NY: Freeman; 1994:580-581.
26. Zou KH, Tuncali K, Silverman SG. Correlation and simple linear regression. Radiology. 2003;227:617-622.
27. Nafe R, Herminghaus S, Raab P, et al. Preoperative proton-MR spectroscopy of gliomas-correlation with quantitative nuclear morphology in surgical specimen. J Neurooncol. 2003;63:233-245.
28. Burtscher IM, Skagerberg G, Geijer B, et al. Proton MR spectroscopy and preoperative diagnostic accuracy: an evaluation of intracranial mass lesions characterized by stereotactic biopsy findings. AJNR Am J Neuroradiol. 2000;21:84-93.
29. Matsumura A, Isobe T, Anno I, et al. Correlation between choline and MIB-1 index in human gliomas. A quantitative in proton MR spectroscopy study. J Clin Neurosci. 2005;12:416-420.
30. Dydak U, Weiger M, Pruessmann KP, et al. Sensitivity-encoded spectroscopic imaging. Magn Reson Med. 2001;46:713-722.
31. Griswold MA, Jakob PM, Heidemann RM, et al. Generalized autocalibrating partially parallel acquisitions (GRAPPA). Magn Reson Med. 2002;47:1202-1210.
32. Gruber S, Mlynarik V, Moser E. High-resolution 3D proton spectroscopic imaging of the human brain at 3 T: SNR issues and application for anatomy-matched voxel sizes. Magn Reson Med. 2003;49:299-306.